AP505F
Goat Anti-Human Ig κ chain Antibody, FITC conjugate
Chemicon®, from goat
조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
제품정보 (DICE 배송 시 비용 별도)
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
FITC conjugate
Clone:
polyclonal
Application:
immunofluorescence
Species reactivity:
human
Citations:
1
Technique(s):
immunofluorescence: suitable
제품 이름
Goat Anti-Human Ig κ chain Antibody, FITC conjugate, Chemicon®, from goat
biological source
goat
conjugate
FITC conjugate
antibody form
affinity purified immunoglobulin
antibody product type
secondary antibodies
clone
polyclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
관련 카테고리
Application
Immunofluorescence: ≤1 μg/106 cells.
Optimal working dilutions must be determined by the end user.
Optimal working dilutions must be determined by the end user.
This Goat anti-Human Ig κ chain Antibody, FITC conjugate is validated for use in IF for the detection of Human Ig κ chain.
Biochem/physiol Actions
Reacts with human kappa light chains. Absorbed for human myeloma proteins with λ light chains.
General description
Antibody molecules typically comprise two immunoglobulin light chains covalently bound to a pair of heavy chains. Immunoglobulin light chains occur in two types, designated by the Greek letters kappa and lambda. Kappa and lambda light chains are approximately 250 amino acids in length with an average mass of about 25 kDa. The ratio of kappa to lambda found in the immunoglobulin population varies by species.
Physical form
Purified by affinity chromatography on pooled human Igs with kappa light chains covalently linked to agarose. Liquid in 1.0 mL PBS/NaN3.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
적합한 제품을 찾을 수 없으신가요?
당사의 제품 선택기 도구.을(를) 시도해 보세요.
저장 등급
10 - Combustible liquids
wgk
WGK 2
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
Joel G Turner et al.
Oncotarget, 7(48), 78896-78909 (2016-11-03)
Acquired proteasome-inhibitor (PI) resistance is a major obstacle in the treatment of multiple myeloma (MM). We investigated whether the clinical XPO1-inhibitor selinexor, when combined with bortezomib or carfilzomib, could overcome acquired resistance in MM. PI-resistant myeloma cell lines both in
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| AP505F | 04053252742941 |
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.